M&A
Olon Continues its Growth Path and Announces a New Acquistion
Olon
PR-09-24-NI-01Sep 04, 2024
Comparability
Leveraging Risk Assessment for Demonstrating Product Comparability after Manufacturing Process Changes
Pawel Stanczak, Ph.D.; Xuemei Han, Ph.D.; Miguel Carrion
Tanvex CDMO
PAO-07-24-CL-08Aug 26, 2024
Biosimilars
Biosimilars: Manufacturing and Supply Chain for Worldwide Patients
Paula Olcese
Biosidus
PAO-08-24-CL-06Aug 07, 2024
Biosimilars
Enhancing Global Access to Biotherapeutics: The Role of Biosimilars in Underserved Markets
Hugo Sotelo; Marcelo Criscuolo
Biosidus
PAO-07-24-CL-07Jul 16, 2024
Biosimilars
Pioneering Affordable Healthcare: Biosidus' Journey in Biosimilars
Hugo Sotelo; Marcelo Criscuolo
Biosidus
PAO-07-24-CL-06Jul 16, 2024
Biosimilars
Navigating the Global Regulatory Landscape for Biosimilars
Veronica Grimoldi
Biosidus
PAO-07-24-CL-09Jul 16, 2024
Chronic Diseases
Transforming the Management of Chronic Diseases with Biosimilars
Hugo Sotelo; Jorge Catella
Biosidus
PAO-07-24-CL-10Jul 16, 2024
Cell Therapy
Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA
Genezen
PR-07-24-NI-01Jul 02, 2024
Synthetic DNA
Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA
Tom Merritt, Ph.D.
Touchlight
PAO-07-24-CL-01Jul 02, 2024
Digitalization
Overcoming Development Challenges with Digital Solutions
Wheeler Bio
PAO-06-24-CL-06Jul 02, 2024
Outsourced Manufacturing
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
April Stanley, MS MBA
Nice Insight
PAO-03-24-NI-02Mar 27, 2024
Advanceability
Right from the Start: Designing Advanceable Formulations and Processes at Phase I
Serán Bioscience
PAO-02-24-CL-09Feb 26, 2024
High Potency API Suite
Expanding Capabilities for Clients:Olon to Open New High Potency API Suite in US
Olon
PR-M02-24-01Feb 05, 2024
Clinical and Commercial Manufacturing
Reach the Patient Quicker with GBI’s Manufacturing Solutions
Muctarr Sesay, Ph.D.
GBI
PAO-08-23-CL-02Aug 08, 2023
Expanded CDMO Capabilities
On the Journey to Support Drug Developers With End-to-End Outsourcing
Michelle Hall
Mikart
PAO-06-23-CL-04Jul 17, 2023
API
Enhanced Solubility through API Processing: Salt and Cocrystal Formation
Thomas Briel, Ph.D.; David Luedeker, Ph.D.
MilliporeSigma
PAO-05-23-CL-04May 05, 2023
Olon, International API Supplier, Releases New 2022 Sustainability Report
Olon
PR-M11-22-08Nov 22, 2022
mRNA Manufacturing
Overcoming Bottlenecks in mRNA Manufacturing
Pierre Catignol; Huisub Lim
Samsung Biologics
PAO-10-022-CL-04Oct 24, 2022
New Facility
Piramal Pharma Solutions Holds Grand Opening Ceremony for New API Plant at Aurora, Canada Manufacturing Site
Piramal Pharma Solutions
PR-M07-22-04Jul 13, 2022
Manufacturing
The Evolving Technology Supporting API Manufacturing
Pharma's Almanac
PAO-04-22-R250-76May 03, 2022